> top > docs > PMC:7402624 > spans > 0-1277 > annotations

PMC:7402624 / 0-1277 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 420-424 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T2 431-435 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T3 502-506 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T4 562-573 Body_part denotes plasmablast http://purl.org/sig/ont/fma/fma84371
T5 615-620 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T6 652-662 Body_part denotes lymphocyte http://purl.org/sig/ont/fma/fma62863

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
2 34-42 Species denotes patients Tax:9606
3 25-33 Disease denotes COVID-19 MESH:C000657245
12 157-162 Species denotes human Tax:9606
13 244-252 Species denotes patients Tax:9606
14 463-471 Species denotes patients Tax:9606
15 487-495 Species denotes patients Tax:9606
16 112-120 Disease denotes COVID-19 MESH:C000657245
17 235-243 Disease denotes COVID-19 MESH:C000657245
18 542-557 Disease denotes viral infection MESH:D001102
19 1029-1037 Disease denotes COVID-19 MESH:C000657245
34 1162-1171 Species denotes SARS-CoV2 Tax:2697049
35 1182-1190 Species denotes patients Tax:9606
37 1044-1052 Disease denotes COVID-19 MESH:C000657245
38 1092-1102 Disease denotes infections MESH:D007239
39 1129-1135 Disease denotes deaths MESH:D003643
40 1147-1156 Disease denotes infection MESH:D007239
41 1173-1181 Disease denotes COVID-19 MESH:C000657245

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 25-33 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T2 112-120 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T3 235-243 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T4 542-557 Disease denotes viral infection http://purl.obolibrary.org/obo/MONDO_0005108
T5 548-557 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T6 1029-1037 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T7 1044-1052 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T8 1092-1102 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T9 1147-1156 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T10 1162-1166 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T11 1173-1181 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 134-135 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T2 157-162 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T3 187-192 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T4 404-414 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T5 418-424 http://purl.obolibrary.org/obo/CL_0000084 denotes T cell
T6 429-435 http://purl.obolibrary.org/obo/CL_0000236 denotes B cell
T7 447-448 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T8 473-474 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T9 500-506 http://purl.obolibrary.org/obo/CL_0000084 denotes T cell
T10 507-517 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T11 613-620 http://purl.obolibrary.org/obo/CL_0000236 denotes B cells
T12 663-673 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T13 1062-1065 http://purl.obolibrary.org/obo/CLO_0051582 denotes has

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T1 163-179 http://purl.obolibrary.org/obo/GO_0006955 denotes immune responses
T2 500-517 http://purl.obolibrary.org/obo/GO_0042110 denotes T cell activation
T3 502-517 http://purl.obolibrary.org/obo/GO_0001775 denotes cell activation
T4 542-557 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infection
T5 652-673 http://purl.obolibrary.org/obo/GO_0046649 denotes lymphocyte activation

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-101 Sentence denotes Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
T2 103-111 Sentence denotes Abstract
T3 112-218 Sentence denotes COVID-19 is currently a global pandemic, but human immune responses to the virus remain poorly understood.
T4 219-333 Sentence denotes We analyzed 125 COVID-19 patients, and compared recovered to healthy individuals using high dimensional cytometry.
T5 334-472 Sentence denotes Integrated analysis of ~200 immune and ~50 clinical features revealed activation of T cell and B cell subsets in a proportion of patients.
T6 473-621 Sentence denotes A subgroup of patients had T cell activation characteristic of acute viral infection and plasmablast responses reaching >30% of circulating B cells.
T7 622-708 Sentence denotes However, another subgroup had lymphocyte activation comparable to uninfected subjects.
T8 709-826 Sentence denotes Stable versus dynamic immunological signatures were identified and linked to trajectories of disease severity change.
T9 827-940 Sentence denotes These analyses identified three “immunotypes” associated with poor clinical trajectories versus improving health.
T10 941-1038 Sentence denotes These immunotypes may have implications for the design of therapeutics and vaccines for COVID-19.
T11 1040-1136 Sentence denotes The COVID-19 pandemic has to date caused >7 million infections resulting in over 400,000 deaths.